{
    "candidate_id": "GPT-4o",
    "identified_issues": [
        {
            "issue_id": "ISSUE_01",
            "source_description": "Protocol Section 4.2 Exclusion Criteria",
            "protocol_reference": "Section 4.2.2",
            "problem_summary": "Exclusion criterion 4.2.2 prohibits 'any prescription or over-the-counter anti-hypertensive medication within 14 days', but does not clarify whether medications with hypertensive effects (e.g., pseudoephedrine) are included.",
            "potential_impact": "Inconsistent subject exclusion due to unclear medication restrictions.",
            "recommended_next_step": "Inform PI and request clarification on whether pseudoephedrine is considered an anti-hypertensive medication for exclusion purposes.",
            "communication_point_person": "Principal Investigator"
        },
        {
            "issue_id": "ISSUE_02",
            "source_description": "Scenario 1",
            "protocol_reference": "Section 4.2.2",
            "problem_summary": "Potential subject took pseudoephedrine (a medication with hypertensive effects) within the 14-day window, but protocol does not explicitly address such medications.",
            "potential_impact": "Risk of enrolling an ineligible subject if pseudoephedrine is considered prohibited.",
            "recommended_next_step": "Notify PI immediately regarding the pseudoephedrine use and await clarification on eligibility.",
            "communication_point_person": "Principal Investigator"
        },
        {
            "issue_id": "ISSUE_03",
            "source_description": "Scenario 2",
            "protocol_reference": "Section 6.2 Table 1",
            "problem_summary": "Patient forgot to fill out diary for Days 13-15, but diary review only occurs at scheduled visits (next at Visit 3). No protocol guidance on handling missed diary entries between visits.",
            "potential_impact": "Incomplete data collection for Days 13-15, potentially affecting study outcomes.",
            "recommended_next_step": "Notify PI of the missed diary entries and document the issue for potential query to sponsor.",
            "communication_point_person": "Principal Investigator"
        },
        {
            "issue_id": "ISSUE_04",
            "source_description": "Scenario 3",
            "protocol_reference": "Scenario Context",
            "problem_summary": "ECG shows 'Borderline QT interval' with recommendation for clinical correlation, but protocol does not define 'clinically significant' findings for ECG results.",
            "potential_impact": "Potential subject safety risk if QT prolongation is not addressed.",
            "recommended_next_step": "Immediately inform PI of the ECG finding for clinical assessment.",
            "communication_point_person": "Principal Investigator"
        },
        {
            "issue_id": "ISSUE_05",
            "source_description": "Protocol Section 6.2 Schedule of Assessments",
            "protocol_reference": "Section 6.2 Table 1 Footnote 1",
            "problem_summary": "Safety labs at Visit 2 require fasting, but protocol does not specify how to confirm/verify fasting status or handle non-fasting samples.",
            "potential_impact": "Risk of invalid lab results if fasting is not properly confirmed.",
            "recommended_next_step": "Flag for discussion with PI to establish a fasting verification process.",
            "communication_point_person": "Principal Investigator"
        },
        {
            "issue_id": "ISSUE_06",
            "source_description": "Protocol Section 4.1 Inclusion Criteria",
            "protocol_reference": "Section 4.1.3",
            "problem_summary": "Inclusion criterion 4.1.3 requires 'prior history of treatment for hypertension' but does not specify timeframe or type of treatment.",
            "potential_impact": "Inconsistent subject screening due to lack of clear treatment history requirements.",
            "recommended_next_step": "Inform PI and request clarification on treatment history specifications.",
            "communication_point_person": "Principal Investigator"
        }
    ]
}